KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Account Payables: 2014-2024

Historic Change in Account Payables for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $121.5 million.

  • BeOne Medicines' Change in Account Payables rose 150.98% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year increase of 2652.60%. This contributed to the annual value of $121.5 million for FY2024, which is 465.52% up from last year.
  • Per BeOne Medicines' latest filing, its Change in Account Payables stood at $121.5 million for FY2024, which was up 465.52% from $21.5 million recorded in FY2023.
  • BeOne Medicines' 5-year Change in Account Payables high stood at $121.5 million for FY2024, and its period low was -$4.4 million during FY2022.
  • In the last 3 years, BeOne Medicines' Change in Account Payables had a median value of $21.5 million in 2023 and averaged $46.2 million.
  • Per our database at Business Quant, BeOne Medicines' Change in Account Payables skyrocketed by 4,209.13% in 2020 and then slumped by 121.75% in 2022.
  • BeOne Medicines' Change in Account Payables (Yearly) stood at $95.8 million in 2020, then crashed by 79.12% to $20.0 million in 2021, then slumped by 121.75% to -$4.4 million in 2022, then soared by 593.66% to $21.5 million in 2023, then surged by 465.52% to $121.5 million in 2024.